Home » Investors » Financials » Quarterly Figures

Quarterly Figures

Quarterly Figures

MSEKApril-June 2026Jan-March 2026Oct-Dec 2025July-Sept 2025April-June 2025Jan-Mar 2025Oct-Dec 2024July-Sept 2024April-June 2024
Net sales336.1329.9451.3386.9324.2334.7515.1369.1423.3
Organic growth, %7.3%11.0%-3.7%12.3%-17.0%-21.8%-0.6%-17.7%1.3%
Gross profit*199.2178.6235.4212.7142.4189.7308.0200.3221.6
Gross margin*, %59.3%54.1%52.2%55.0%43.9%56.7%59.8%54.3%52.3%
Operating income before depreciation and amortization (EBITDA)15.6-42.436.84.8-52.5-21.4107.54.313.4
EBITDA margin, %4.6%-12.9%8.1%1.2%-16.2%-6.4%20.9%1.2%3.2%
Operating profit (EBIT)-41.6-113.5-25.9-1,083.3-105.4-77.9-8.3-64.3-49.6
Operating margin (EBIT), %12.4%-34.4%-5.7%-280.0%-32.5%-23.3%-1.6%-17.4%-11.7%
Net profit/loss from continuing operations-37.2-131.3-59.2-1,107.5-181.7-235.4250.5-260.8-81.2
Cash flow from operating activities-53.047.351.5-31.5-28.276.6181.645.0-50.9-17.3
Average number of shares70 574 89570 574 89570 574 89570 574 89570 574 89570 574 89570 574 89570 574 89570 574 895
Number of shares at closing day70 574 89570 574 89570 574 89570 574 89570 574 89570 574 89570 574 89570 574 89570 574 895
Earnings per share after dilution, SEK-0.53-1.86-0.84-15.68-2.55-3.323.56-3.68-1.14
Share price at closing day, SEK161721203631324544
Market cap at closing day, BSEK1.11.21.51.42.52.22.33.13.1
Average number of employees at closing day in continuing operations554557567586599606621627642
All numbers on this page refers to Nanoscribe being classified as discontinued operations from Q4 2024, Mattek and Visiokol from Q3 2025 with retroactive effect. * From Q1 2024, BICO has changed to functional reporting with retroactive effect, mainly impacting the reporting of gross profit and gross margin compared to prior periods.

Contact us!

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.